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Background: The mediopatellar plica is a synovial fold representing an embryonic remnant from the
developmental process of the synovial cavity formation in the knee. We aimed to examine the frequency of
MRI-detected mediopatellar plica and its cross-sectional association with MRI-detected cartilage damage and bone
marrow lesions (BMLs) in the patellofemoral joint (PFJ) in a cohort of subjects with knee pain.
Methods: 342 knees with chronic frequent knee pain were evaluated for MRI-detected mediopatellar plica (type A,
B or C according to the modified Sakakibara classification). Cartilage damage (scored 0 to 6) and BMLs (scored 0 to
3) were semiquantitatively assessed in four subregions of the PFJ on MRI. Hoffa-synovitis and effusion-synovitis were
graded 0 to 3. Patellar length ratio (PLR), lateral patellar tilt angle (LPTA), bisect offset (BO), and sulcus angle (SA)
were measured on MRI. The presence of mediopatellar plica and its association with cartilage damage and BMLs in
the PFJ was assessed using logistic regression after adjusting for age, gender, body mass index, PLR, LPTA, BO, SA,
and Hoffa- and effusion-synovitis.
Results: 163 (47.7%) knees exhibited mediopatellar plica (76 (22.2%) type A, 69 (20.2%) type B, and 18 (5.3%) type
C) on MRI. Significant cross-sectional associations of MRI-detected mediopatellar plica and cartilage damage were
observed for the medial patella (adjusted odds ratio (aOR) 2.12, 95% CI 1.23-3.64 for all types combined, and aOR
4.20, 95% CI 1.92-9.19 for type B lesion), but not for the anterior medial femur or the lateral PFJ. No associations
were found between the presence of MRI-detected mediopatellar plica and BMLs in any patellofemoral subregion.
Conclusion: On MRI, types A and B mediopatellar plicae were commonly observed in this cohort of subjects with
knee pain. MRI-detected mediopatellar plica was cross-sectionally associated with higher likelihood of the presence
of MRI-detected medial patellar cartilage damage after adjustment for confounders.
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The mediopatellar plica, also known as the medial syn-
ovial shelf, plica synovialis mediopatellaris or plica
alaris elongata, is a synovial fold representing an embry-
onic remnant from the developmental process of the
synovial cavity formation in the knee [1]. It can be dir-
ectly visualized by arthroscopy, but can also be evalu-
ated non-invasively using conventional MRI. Sakakibara
arthroscopically classified the mediopatellar plicae into
four types (A - D) on the basis of size, which is cur-
rently the universally accepted classification scheme
amongst orthopedic surgeons and radiologists [2-4].
Asymptomatic synovial plicae may be found within
structurally normal knee joints. However, direct trauma,
repetitive sports activities, or other pathologic knee
conditions may provoke secondary inflammation in the
synovial tissues surrounding the plica, and may result in
increasing fibrotic changes, loss of elasticity, and various
degrees of synovitis [4,5]. Owing to the anatomic loca-
tion of the mediopatellar plica, a loss of normal elasti-
city can cause impingement of the plica between the
medial femoral condyle and the medial facet of the
patella during flexion-extension motion of knee [6]. A
high frequency of degenerative chondral lesions on the
facing medial patella and femoral condyle was observed
in patients with mediopatellar plicae in arthroscopic
studies [6,7].
Several studies have shown that anatomical variants/
malalignment of the PFJ such as patellar alta, medial pa-
tellar inclination and trochlear dysplasia are associated
with an increased risk of MRI-detected cartilage loss in
the medial PFJ [8-11]. However, to the authors’ know-
ledge, there has been no MRI-based study that examined
the frequency of the mediopatellar plica and its associ-
ation with structural changes in the PFJ, although there
have been several reports based on arthroscopic findings.
Bone marrow changes, a finding commonly observed in
conjunction with cartilage damage and osteoarthritis,
can be studied with MRI but not with arthroscopy. As-
sociations between MRI-detected cartilage damage and
bone marrow lesions (BMLs) in the knee, including the
PFJ, have been reported [12,13]. Thus, BMLs may also
potentially be associated with the mediopatellar plica.
Anatomical variants have been shown to be associated
with MRI-assessed cartilage damage and BMLs [9,14]. It
is unknown if the MRI-detected plica by itself has a rele-
vant impact on the structural changes or if they are a re-
sult of the anatomical variants.
Aim of the present study was to examine the preva-
lence of mediopatellar plica on MRI in persons with
chronic frequent knee pain and to investigate the cross-
sectional association of knee pain with MRI-detected
structural damage in the PFJ, i.e. cartilage damage and
BMLs.Methods
Study sample
Subjects included in the present study were participants
in the Joints On Glucosamine (JOG) study (clinical trial
registration number: NCT00377286). The JOG study is a
6-month, double-blind, randomized controlled trial to
examine the efficacy of oral glucosamine supplementation.
Two hundred and one participants, aged 35 to 65 with
mild to moderate chronic, frequent knee pain (Western
Ontario and McMaster Universities (WOMAC) score ≥
125 and ≤500 [15]), were recruited at the University of
Pittsburgh, PA, USA. Subjects were excluded from JOG if
they screened positive for rheumatoid arthritis; had an-
kylosing spondylitis, psoriatic arthritis, chronic reactive
arthritis; or renal insufficiency that required hemo- or
peritoneal dialysis; were taking bisphosphonates or diet-
ary supplements for knee pain in the 6 months prior to
study entry; had a history of cancer (except for non-
melanoma skin cancer); had or planned to have bilateral
knee replacement surgery; or were unable to walk with-
out assistance.
The baseline and follow-up MRI examinations of 346
knees of the 177 subjects who completed the study were
examined. Although the JOG study itself was a longitudinal
study, the present study involved only cross-sectional ana-
lyses of the baseline MRI examinations. Because of the
image degradation due to motion artifacts four knees were
excluded. As a result, 342 knees of the 177 subjects were
included in the analyses.
Institutional Review Board approval at the University
of Pittsburgh and written informed consent from all par-
ticipants were obtained for the present study.
Magnetic resonance imaging acquisition
MRI of each knee was performed using a 3 Tesla MR
system (Siemens Trio, Erlangen, Germany). The protocol
used for the Osteoarthritis Initiative was applied in the
JOG study, excluding the fast low angle shot sequence
and the multi-echo spin echo T2 mapping sequence. De-
tails of the full Osteoarthritis Initiative pulse sequence
protocol and the sequence parameters have been pub-
lished [16]. The protocol included the sagittal triplanar
three-dimensional dual echo at steady state (3D DESS)
sequence (slice thickness = 0.7 mm, interslice gap = 0 mm,
repetition time = 16.3 ms, echo time = 4.7 ms, flip angle =
25°, field of view = 140 mm× 140 mm, matrix = 384 × 307
pixels, echo train length = 1, number of slices = 35, band-
width = 185 Hz/pixel, number of excitations = 1, anterior/
posterior phase encoding axis, acquisition time = 10 mi-
nutes 23 seconds) and the sagittal intermediate-weighted
fat-suppressed (IW FS) sequence (slice thickness =
3 mm, interslice gap = 0 mm, repetition time = 30 ms,
echo time = 3,200 ms, flip angle = 180°, field of view =
160 mm × 160 mm, matrix = 313 × 448 pixels, echo train
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pixel, number of excitations = 1, anterior/posterior phase
encoding axis, acquisition time = 4 minutes 42 seconds).
Axial and coronal images were reformatted from the sagit-
tal 3D DESS images.
Magnetic resonance imaging assessment
All MRI assessments were performed blinded to clinical
information of subjects using digital imaging software
(eFilm Workstation, version 2.1.2, Merge Healthcare,
Milwaukee, WI).
Mediopatellar plicae evaluation
From the baseline MRI of each knee, mediopatellar plica
was scored by a musculoskeletal radiologist (LX) with
6 years of experience in musculoskeletal radiology and
1 year of research experience using semiquantitative scor-
ing of knee MRI. Based on the Sakakibara arthroscopic
classification [2], we developed an MRI grading system for
the present study, which took into account the size of theFigure 1 MRI classification scheme of mediopatellar plicae modified f
the left knee consisting of a cord-like elevation in the synovial wall; (B) Typ
not cover the anterior surface of the medial trochlea; (C) Type C lesion in t
anterior surface of the medial trochlea.mediopatellar plica in relation to the anterior medial
trochlea. In our MRI grading system, mediopatellar plica
was scored according to their size: 0 = no obvious
mediopatellar plica; 1 = corresponds to Sakakibara Type A
lesion consisting of a cord-like elevation in the synovial
wall; 2 = corresponds to Type B lesion which has a shelf-
like appearance but does not cover the anterior surface of
the medial trochlea; 3 = corresponds to Type C lesion
which has a large shelf-like appearance and covers the an-
terior surface of the medial trochlea (Figure 1). Although
the Sakakibara classification also includes a Type D lesion
(fenestrated plica), these type D lesions are rare and no
comparative arthroscopic-MRI studies are available that
have characterized these lesions on MRI [2,3].
Patellar alignment measurements
Of the 342 knees, patellar alignment was not measurable
in 9 knees due to patellar dysplasia, anterior cruciate
ligament (ACL) tears or susceptibility artifacts resulting
from previous ACL reconstruction surgeries. These 9rom the Sakakibara arthroscopic classification. (A) Type A lesion in
e B lesion in the left knee, which has a shelf-like appearance but does
he left knee, which has a large shelf-like appearance and covers the
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measurements of the PFJ were performed on the base-
line MRI of 333 knees by one radiologist (LX) who also
evaluated the mediopatellar plica according to the Insall
and Salvati method [17]. On the sagittal slice at the mid-
dle of the medial patellar facet, patellar length (PL) and
patellar tendon length (TL) were measured and the pa-
tellar length ratio (PLR = PL/TL) was then calculated
(Figure 2A). On the axial slice through the level of the
superior 1/3 of the trochlea, sulcus angle (SA) was mea-
sured as the angle between two lines, one connecting
the lowest point of the trochlear sulcus and the medial
trochlear bony margin, and the other connecting the
lowest point of the trochlear sulcus and the lateral
trochlear bony margin (Figure 2B). Lateral patellar tilt
angle (LPTA) and bisect offset (BO) were measured on
the specific axial slice defined by the bisecting line be-
tween the superior and inferior osseous patellar pole.
LPTA is the angle between the posterior condylar line
and the line drawn through the lateral inferior bonyFigure 2 Schema of measured patellar alignment indices. (A) The sagi
(PL, white broken line), patellar tendon length (TL, black line) and patellar l
level of superior 1/3 of trochlea, sulcus angle (SA) was measured; (C) and (
between the superior and inferior osseous patellar pole, lateral patellar tiltmargin of the patella (Figure 2C). For BO measurement,
two lines were drawn: one line connecting the medial
and lateral poles of the patella and a vertical line perpen-
dicular to the posterior condylar line and across the low-
est point of the trochlear sulcus. The first line is bisected
by the vertical line, the sections representing (a) the dis-
tance between the lateral border of the patella and the
intersection point of the two lines and (b) the distance
between the medial border of the patella and the inter-
section of the two lines (Figure 2D). BO was calculated
according to the formula: BO = a*100/(a + b).
Semiquantitative assessment of structural patellofemoral
joint damage
Severity of cartilage damage, subchondral BMLs, Hoffa-
synovitis and effusion synovitis at baseline were semi-
quantitatively assessed for all knees (n = 342) by another
musculoskeletal radiologist (FWR) with 7 years experi-
ence of semiquantitative assessment of knee MRI, using
the Whole Organ Magnetic Resonance Imaging Score,ttal slice referring to the middle of medial patellar facet: patellar length
ength ratio (PLR = PL/TL) were measured; (B) On the axial slice at the
D) On the specific axial slice that was defined by the bisecting line
angle (LPTA) and bisect offset (BO = a*100/(a + b)) were measured.
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in the articular subregions according to WORMS: the
medial patella, the lateral patella, the anterior medial femur
and the anterior lateral femur. Using the axial, sagittal, and
coronal DESS images, and the sagittal IW FS images,
cartilage damage was scored from 0 to 6 based on the
thickness of cartilage loss and the extent of regional in-
volvement (0 = normal thickness; 1 = focal swelling of car-
tilage without thickness loss; 2.0 = partial-thickness focal
defect < 1 cm in greatest width; 2.5 = full-thickness focal
defect <1 cm in greatest width; 3 =multiple areas of
partial-thickness (grade 2.0) defects intermixed with areas
of normal thickness, or a grade 2.0 defect wider than 1 cm
but <75% of the region; 4 = diffuse (≥75% of the region)
partial-thickness loss; 5 =multiple areas of full-thickness
loss (grade 2.5) or a grade 2.5 lesion wider than 1 cm but
<75% of the region; 6 = diffuse (≥75% of the region))
(Figure 3B). On the sagittal IW FS images, subchondral
BMLs were scored from 0 to 3 based on the extent of sub-
regional marrow involvement (0: none; 1: < 25% of the re-
gion; 2: 25-50% of the region; 3: >50% of the region).
Effusion-synovitis was graded from 0 to 3 in regard to the
estimated maximum distention of the synovial cavity (0:
normal; 1: < 33% of maximum potential distention; 2: 33–
66% of maximum potential distention; 3: > 66% of max-
imum potential distention) (Figure 4B). Hoffa-synovitis at
the infrapatellar and intercondylar sites was graded 0 to 3
according to the degree of signal changes in Hoffa’s fat pad
(0 = none; 1 =mild; 2 =moderate; 3 = severe).
Statistical analysis
We collapsed WORMS grades of MRI assessment features
(cartilage damage, BMLs, effusion synovitis and Hoffa-
synovitis) into absent or present (WORMS grade ≥ 2 for
cartilage damage and ≥ 1 for all other features). WeFigure 3 Type C mediopatellar plica with cartilage damage and BMLs
shows a type C mediopatellar plica (white arrow). (B) Sagittal intermediate-
thickness focal defect (white arrow) and a corresponding WORMS grade 1considered a grade 1 cartilage lesion to be within normal
limits, as these changes represent intrachondral signal
changes of unknown clinical relevance with an intact ar-
ticular surface. Logistic regression was performed to assess
the cross-sectional relationships between the presence of
mediopatellar plica and cartilage damage as well as BMLs
in each compartment of 333 knees. Adjustment for con-
founders of PFJ structural damage was performed for the
following: patellar alignment (PLR, LPTA, BO, and SA, as
described above), age, gender, body mass index (BMI), and
Hoffa- and effusion-synovitis [19]. For covariate adjust-
ment, BMI was categorized as 1: < 25 kg/m2, 2: 25-30 kg/
m2 and 3: > 30 kg/m2. We did not adjust for malalignment
of the tibiofemoral knee joint (i.e. varus and valgus) be-
cause a recent large-scale study showed a lack of signifi-
cant difference in the prevalence of medial PFJ cartilage
damage in varus, valgus and neutrally aligned knees. All
statistical analyses were performed using SAS software
(Version 9.2 for Windows; SAS Institute, Cary, NC).
Results
The present study included 177 participants with a mean
age of 52 years (range: 35 to 65 years, standard deviation
(SD) ± 6) and a mean BMI of 29 kg/m2 (SD ± 4). The per-
centages of overweight (25-30 kg/m2) and obese (> 30 kg/
m2) subjects were 40.1% (71) and 41.2% (73), respectively.
Subjects were predominantly white (90.4%, 160) and ap-
proximately half were women (46.3%, 82). Of the 342
knees, 163 (47.7%) knees exhibited mediopatellar plica. Of
the 163 mediopatellar plicae, 46.6% (76/163) were type A,
42.3% (69/163) were type B, and 11.0% (18/163) were type
C, according to our MRI grading scheme. The Kellgren
and Lawrence grades for the 342 knees were: grade 0 =
105 knees (30.7%), grade 1 = 30 (8.8%), grade 2 = 38
(11.1%), grade 3 = 153 (44.7%), and grade 4 = 16 (4.7%).in the medial patella. (A) Axial dual echo steady-state (DESS) image
weighted fat-suppressed (IW FS) image shows a WORMS grade 2.5 full
BML in the medial patella (grey arrow).
Figure 4 Type A mediopatellar plica with a bone marrow lesion (BML) in the anterior medial femur. (A) Axial dual echo steady-state
(DESS) image shows a type A mediopatellar plica (white arrow). (B) Sagittal intermediate-weighted fat-suppressed (IW FS) image shows a WORMS
grade 1 BML in the anterior medial femur (grey arrow head), a finding that was not associated with mediopatellar plica.
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cartilage damage was 66.3% for knees with mediopatellar
plica and 58.1% for knees without mediopatellar plica
(Table 1). In the anterior medial femur, the frequency of
any MRI-detected cartilage damage was 42.3% for knees
with mediopatellar plica and 37.4% for knees without
mediopatellar plica. The frequency of BMLs for knees with
and without mediopatellar plica was 26.4% and 29.6% in
the medial patella and 18.4% and 16.8% in the anterior
medial femur, respectively (Table 2).
There was a strong cross-sectional association between
the presence of MRI-detected mediopatellar plica (all
types combined and type B) and medial patellar cartilage
damage, with an adjusted odds ratio (aOR) of 2.12 (95%
confidence interval (CI), 1.23-3.64) (Table 3). No signifi-
cant association between the presence of MRI-detected
mediopatellar plica and cartilage damage was detected
for the anterior medial femur or the lateral PFJ subregions.
There was no significant cross-sectional association be-
tween the presence of MRI-detected mediopatellar plica
and BMLs in any subregion of the PFJ (Table 4).Table 1 Frequency of MRI-detected cartilage damage (WORM
presence of MRI-detected mediopatellar plica
Compartment Total Without
mediopatellar plica
(N = 342) (N = 179)
Medial patella 212 (62.0%) 104 (58.1%)
Lateral patella 141 (41.2%) 80 (44.7%)
Anterior medial femur 136 (39.8%) 67 (37.4%)
Anterior lateral femur 90 (26.3%) 49 (27.4%)Discussion
In summary, type A and B mediopatellar plicae were
much more commonly observed on MRI than type C
plicae. There was a strong cross-sectional association be-
tween the presence of MRI-detected mediopatellar plica
and medial patellar cartilage damage but not in other
subregions of the PFJ. We did not find any significant
cross-sectional association between the presence of MRI-
detected mediopatellar plica and BMLs in any subregion
of the PFJ.
The prevalence of mediopatellar plica has been
reported with wide variation, ranging from 18.5 to 80%.
Most data were collected from knee arthroscopic sur-
gery on patients with knee symptoms or trauma [3,6,7].
According to a recent large-scale retrospective study
performed by Nakayama and colleagues, 79.9% of 3889
symptomatic knees were found to have mediopatellar
plica confirmed by arthroscopic surgery [3]. In their
study, the incidence of Sakakibara type A, B, C and D
mediopatellar plicae was 35.2%, 22.4%, 12.3% and
10.0%, respectively. We found similar numbers for theS grade ≥ 2) in the patellofemoral joint stratified by the
With mediopatellar plica
All types Type A Type B Type C
N = 163 N = 76 N = 69 N = 18
108 (66.3%) 44 (57.9%) 55 (79.7%) 9 (50.0%)
61 (37.4%) 19 (25.0%) 30 (43.5%) 12 (66.7%)
69 (42.3%) 28 (36.8%) 33 (47.8%) 8 (44.4%)
41 (25.2%) 15 (19.7%) 20 (29.0%) 6 (33.3%)
Table 2 Frequency of bone marrow lesions (BMLs) in the patellofemoral joint stratified by the presence of MRI-
detected mediopatellar plica
Compartment Total Without mediopatellar
plica
With mediopatellar plica
All types Type A Type B Type C
(N = 342) (N = 179) N = 163 N = 76 N = 69 N = 18
Medial patella 96 (28.1%) 53 (29.6%) 43 (26.4%) 13 (17.1%) 23 (33.3%) 7 (38.9%)
Lateral patella 101 (29.5%) 58 (32.4%) 43 (26.4%) 16 (21.1%) 20 (29.0%) 7 (38.9%)
Anterior medial femur 60 (17.5%) 30 (16.8%) 30 (18.4%) 14 (18.4%) 12 (17.4%) 4 (22.2%)
Anterior lateral femur 67 (19.6%) 34 (19.0%) 33 (20.3%) 10 (13.2%) 17 (24.6%) 6 (33.3%)
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detected mediopatellar plicae following the same trend
(A > B > C) in our cohort. Another large-scale retrospect-
ive study by Lyu and colleagues based on arthroscopic
evaluation found 472 (29.7%) of 1587 symptomatic knees
had mediopatellar plica [6]. Christoforakis and colleagues
prospectively evaluated 1000 symptomatic knees using
arthroscopy and found 321 (32.1%) knees exhibiting a
mediopatellar plica [7]. Different definitions of medio-
patellar plica exist: some authors describe a small fold of
synovium as a plica and others describe it as absent, and
reported prevalence has to be interpreted carefully [1].
Further, variation in study populations contributes to the
wide range of prevalence estimates reported in the litera-
ture, and the present study population included mainly
overweight and obese adults with knee pain in whom
tibiofemoral OA was also highly prevalent.
Our findings are based solely on MRI findings, and
there can potentially be a discrepancy between our find-
ings and arthroscopic findings with respect to evaluation
of mediopatellar plica. Thus, results of our study need to
be interpreted with caution when comparing them to
arthroscopy-based studies. Studies reporting the preva-




(N = 333) (N = 179)
Medial patella 96 1.00
(28.1%) (Reference)
Lateral patella 101 1.00
(29.5%) (Reference)
Anterior medial femur 60 1.00
(17.5%) (Reference)
Anterior lateral femur 67 1.00
(19.6%) (Reference)
*Numbers in boldface represent statistically significant results with p<0.05.
**Adjustment for age, gender, BMI, PLR, SA, LPTA, BO, effusion synovitis, Hoffa’s syn
NB) 9 knees without measurement of malalignment were excluded.MRI seems to be sensitive for the detection of me-
diopatellar plica [4,20]. According to a report by Jee and
colleagues, the sensitivity of MRI for detection of
mediopatellar plica, using arthroscopic findings as the
gold standard, was 71-95%, and the specificity 72-83%,
depending on the pulse sequence used [21]. A study
by Nakanishi and colleagues showed 27 (93.1%) of the
29 arthroscopy-detected mediopatellar plica were also
detected by MRI [20]. Boles and colleagues reported
that 46 (69.7%) of 66 symptomatic knees demonstrated
a mediopatellar plica on MRI [22]. Consistent with the
present study, then, the presence of mediopatellar plica,
whether it be detected by MRI or arthroscopy, seems to
be fairly common in symptomatic knees.
Mediopatellar plica may cause snapping and impinge-
ment within the medial PFJ during knee motion and are
believed to contribute to degenerative chondral lesions
in the medial PFJ compartment [5,6,23,24]. Lyu and col-
leagues found that 97% of the symptomatic knees with
arthroscopy-detected mediopatellar plica had degenera-
tive cartilage damage on the edge and the anterior part
of the medial femoral condyle [6]. Furthermore, the
severity of the degenerative cartilaginous lesions was
positively correlated with the severity of the pathologicellar plica with cartilage damage (WORMS grade ≥ 2) in
With mediopatellar plica
Adjusted odds ratio (95% confidence interval)**
All types Type A Type B Type C
N = 159 N = 76 N = 69 N = 18
2.12* 1.87 4.20* 0.68
(1.23–3.64) (0.94-3.71) (1.92-9.19) (0.23-2.06)
1.06 0.65 1.45 2.36
(0.62-1.81) (0.31-1.38) (0.71-2.99) (0.70-8.03)
1.17 1.02 1.21 1.86
(0.70-1.96) (0.52-2.00) (0.62-2.39) (0.58-5.94)
1.19 1.07 1.21 1.31
(0.65-2.20) (0.48-2.40) (0.54-2.71) (0.38-4.54)
ovitis.
Table 4 Cross-sectional association of MRI-detected mediopatellar plica with bone marrow lesions (WORMS grade ≥ 1)




Adjusted odds ratio (95% confidence interval)*
All types Type A Type B Type C
(N = 333) (N = 179) N = 159 N = 76 N = 69 N = 18
Medial patella 96 1.00 1.35 0.79 1.90 1.89
(28.1%) (Reference) (0.77 – 2.34) (0.36-1.71) (0.94-3.80) (0.63-5.67)
Lateral patella 101 1.00 1.17 1.00 1.20 1.59
(29.5%) (Reference) (0.67 – 2.04) (0.47-2.15) (0.58-2.50) (0.51-4.95)
Anterior medial femur 60 1.00 0.95 0.92 0.66 2.75
(17.5%) (Reference) (0.51 – 1.78) (0.41-2.04) (0.28-1.54) (0.71-10.68)
Anterior lateral femur 67 1.00 1.55 1.02 1.62 2.97
(19.6%) (Reference) (0.81 – 2.99) (0.41-2.51) (0.71-3.68) (0.86-10.23)
*Adjustment for age, gender, BMI, PLR, SA, LPTA, BO, effusion synovitis, Hoffa’s synovitis.
NB) 9 knees without measurement of malalignment were excluded.
Hayashi et al. BMC Musculoskeletal Disorders 2013, 14:292 Page 8 of 10
http://www.biomedcentral.com/1471-2474/14/292changes of the mediopatellar plica [6]. Christoforakis
and colleagues demonstrated a significantly increased
incidence of cartilage damage in the medial patella
(47.7% vs 27.5%, P < 0.001) and the anterior medial
femoral condyle (80.2% vs 45.0%, P < 0.001) in patients
with arthroscopy-detected mediopatellar plica com-
pared to those without, and an association of larger
and more fibrotic plica with larger cartilage lesions was
observed [7].
In contrast, in our study the presence of any type of
MRI-detected mediopatellar plica correlated significantly
with cartilage damage at the medial patellar facet (aOR:
2.11, 95% CI: 1.23-3.62) but not in the anterior medial
femur (aOR: 1.23, 95% CI: 0.80-1.89). Compared to re-
ports by Christoforakis and colleagues [7], we found a
higher frequency of cartilage damage in the medial pa-
tella for knees with and without mediopatellar plica, and
a much lower frequency of cartilage damage in the an-
terior medial femur for knees with mediopatellar plica.
However, Christoforakis’s subjects were symptomatic
younger patients (mean age, 37.4 years) who underwent
arthroscopy because of knee pain, locking or instability,
and one third of them had a history of knee injury [7].
Thus, their study sample is not comparable to ours and
may explain the discrepancy in the frequency of cartilage
damage in the medial trochlea compared to our study.
Other studies reported associations between medio-
patellar plica and cartilage lesions in the anterior medial
femur [6,7,25]. The lack of this finding in our study may
be attributed to the presence of a relatively small num-
ber of large mediopatellar plica in our cohort, and pos-
sibly to the fact that our study is solely based on MRI
which has a different diagnostic performance for detec-
tion of plica compared to arthroscopy.
The size and morphology of mediopatellar plica seem
to have a role in femoral impingement and chondraldamage [22,26]. The cross-sectional association between
the mediopatellar plica and medial patellar cartilage
damage detected in the present study suggests that med-
ial patellar cartilage is more susceptible to the mechan-
ical abrasion caused by the mediopatellar plica than the
anterior medial femur. Localized synovitis might play an
additional role, but we did not assess synovitis at
separate locations other than those described. Further,
without contrast-enhanced MRI, synovitis cannot be vi-
sualized adequately [27,28]. In line with the literature,
we found that coexistence of the mediopatellar plica and
cartilage damage in the medial patella seems to be a
common finding in symptomatic knees. Thus, close
evaluation of the medial patellar cartilage and evaluation
for the presence of a mediopatellar plica should be part
of routine MRI assessment of symptomatic knees.
In a cross-sectional analysis with MRI-detected cartil-
age damage, type A plicae showed a borderline signifi-
cant increase in the adjusted odds ratio (aOR) while type
B lesions showed a significant increase in the aOR. From
these results, it remains unclear whether patients with a
type A (i.e. very small) mediopatellar plica might benefit
from ‘prophylactic’ treatment or could be safely left alone.
A clinically relevant question to ask here is whether the
presence of type A (and also B and C) plica would cause
future cartilage loss or progression of pre-existing cartil-
age damage. Although we would have liked to do longitu-
dinal analyses, we did not have sufficient numbers of each
type of plicae that showed longitudinal changes over the
6-month follow-up period of the parent JOG study.
To the authors’ knowledge, this is the first study to
examine the association between MRI-detected medio-
patellar plica and BMLs in the PFJ. BMLs in OA repre-
sent subchondral bone changes as a result of localized
increased loading [29]. Pathologically, mediopatellar
plica behaves like bowstrings leading to impingement or
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found an association bewteen the presence of MRI-
detected mediopatellar plica and cartilage damage in the
medial patellar facet but such association was not ob-
served for subchondral BMLs. Since cartilage damage is
commonly associated with BMLs, one could also expect
a higher prevalence of BMLs at the medial patella.
There is little data on BMLs in the PFJ but recent longi-
tudinal data from the JOG study showed that risk fac-
tors for short term progressive cartilage damage differ
between the TFJ and the PFJ [19]. In the study, BMLs
strongly predicted cartilage loss in the TFJ but not the
PFJ, suggesting a different role of BMLs in regard to
structural progression and associated localized joint
damage. Our findings imply that BMLs are probably a
consequence of compressive overloading (which applies
to tibiofemoral joint) rather than frictional wear (which
applies to patellofemoral joint). Lateral trochlear inclin-
ation and quadriceps weakness have been associated
with cartilage damage and BMLs in the lateral PFJ
compartment [10,11]. In the medial PFJ compartment,
quadriceps weakness was found to increase risk only of
cartilage damage [10]. We did not observe any statisti-
cally significant differences in aORs for the presence of
BMLs with any type of mediopatellar plicae (Table 4).
Longitudinal analysis of BMLs was not possible because
too few knees exhibited longitudinal changes.
There are several limitations of the present study. A
major limitation is that only a cross-sectional relation-
ship between the presence of mediopatellar plica and
cartilage damage and BMLs was examined. Although the
JOG study is a 6-month longitudinal study, only a very
few cases (less than 5%) were detected with progression
of cartilage damage or BMLs in the PFJ at the follow-up
visit [19]. Another limitation is that the cohort of this
study is heterogeneous and relatively small, and more-
over all subjects had chronic knee pain but not necessar-
ily knee OA. One cannot discuss the actual prevalence
of mediopatellar plica in the population based on this se-
lected cohort of subjects with knee pain. A much lower
frequency of type C plica compared to types A and B is
also a limitation, as it is likely that the number of type C
lesions did not give us sufficient statistical power to
make a meaningful assessment of aOR values. Since type
C lesions are larger than type B lesions, an aOR value
higher than those for types A or B lesions was expected
but this was not the case in our study. Our hypothesis
needs to be confirmed by a study with a much larger fre-
quency of type C plica.
Conclusions
In conclusion, in this cohort of subjects with knee pain,
MRI-detected type A and B mediopatellar plicae were
common, while type C plicae were rare. The presence ofany type of mediopatellar plica on MRI was cross-
sectionally associated with higher likelihood of the pres-
ence of MRI-detected medial patellar cartilage damage
after adjustment for multiple structural and demographic
risk factors of PFJ cartilage damage. A longitudinal study
is warranted to assess whether the presence of baseline
mediopatellar plica predicts worsening of cartilage damage
and associated BMLs in the PFJ.
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